Ambry Genetics

Ambry Genetics has established itself as an industry leader in clinical genetic diagnostics with a track record of first-to-market innovations. It was the first to offer full CFTR gene sequencing in a clinical setting and among the earliest to provide comprehensive hereditary cancer panels. Its tests are widely adopted by clinicians for patient care decisions. The company operates one of the largest CLIA/CAP-certified labs globally and continues to expand its offerings through collaborations with academic institutions and pharmaceutical partners. No traditional "clinical results" apply since it provides diagnostic services rather than drugs.